NON-COMPACTION MYOCARDIUM OF THE LEFT VENTRICLE: SECONDARY PREVENTION OF THROMBOEMBOLISM
https://doi.org/10.15829/1728-8800-2017-1-100-104
Abstract
Main clinical specifics of the non-compaction myocardium of left ventricle (NCM) are heart failure, arrhythmias and thromboembolism. Severe trabecularity and deep intertrabecular spaces might be the origin of blood congestion and formation of clots inside the left ventricle (LV). The article focuses on the recent aspects of anticoagulation in NCM, and presents clinical case of man 54 year old with NCM diagnosis, admitted with symptoms of severe heart failure and multiple clots in LV, complicated with repeat systemic embolism. Later, after patient’s voluntarily decrease of treatment, repeat thrombosis of the LV developed, with embolism in the left brachial and in popliteal arteries. All patients with NCM, as asecondary prevention of thromboembolism, a permanent anticoagulation is indicated. Also, as a primary prevention, anticoagulation is needed for NCM patients who need thromboembolism risk factors, such as atrial fibrillation and systolic dysfunction of the LV.
About the Authors
R. P. MyasnikovRussian Federation
О. V. Kulikova
Russian Federation
М. S. Kharlap
Russian Federation
S. N. Koretsky
Russian Federation
Е. Yu. Andreenko
Russian Federation
E. A. Mershina
Russian Federation
V. Е. Sinitsin
Russian Federation
S. А. Boytsov
Russian Federation
References
1. Brian CW, Vijay DS, Kevin MM. Noncompaction of the ventricular myocardium. Circulation 2004; 109: 2965-71.
2. Sedmera D, Pexieder T, Vuillemin M, et al. Developmental patterning of the myocardium. Anat Rec 2000; 258: 319-37.
3. Ker J, Van Der Merwe C. Isolated left ventricular noncompaction as a cause of thrombo-embolic stroke: a case report and review. Cardiovasc J S Afr 2006; 17:146-7.
4. Ritter M, Oechslin E, Sutsch G, et al. Isolated noncompaction of the myocardium in adults. Mayo ClinProc 1997; 72: 26-31.
5. Hascelik S, Yalnizoglu D, Kafali G, et al. Stroke owing to noncompaction of myocardium. J Child Neurol 2003; 18: 437-9.
6. Stollberger C, Finsterer J. Thrombi in left ventricular hypertrabeculation/ noncompaction: review of the literature. ActaCardiol 2004; 59: 341-4.
7. Stollberger C, Finsterer J. Left ventricular hypertrabeculation/noncompaction and stroke or embolism. Cardiology 2005; 103: 68-72.
8. Eilen D, Peterson N, Karkut C, et al. Isolated non-compaction of the left ventricular myocardium: a case report and literature review. Echocardiography 2008; 25(7): 755-61.
9. Oechslin EN, AttenhoferJost CH, Rojas JR, et al. Long-term follow-up of 34 adults with isolated left ventricular noncompaction: a distinct cardiomyopathy with poor prognosis. JACC 2000; 36(2): 493-500.
10. Cevik C, Shah N, Wilson JM, et al. Multiple left ventricular: in a patient with left ventricular noncompaction. Texas Heart Institute J 2012; 39(4): 550-3.
11. Stöllberger C, Blazek G, Dobias C, et al. Frequency of stroke and embolism in left ventricular hypertrabeculation/noncompaction. The Am J Cardiology 2011; 108(7): 1021-3.
12. Ritter M, Oechslin E, Sutsch G, et al. Isolated noncompaction of the myocardium in adults. Mayo ClinProc 1997; 72(1): 26-31.
13. Yelamanchili P, Nanda NC, Patel V, et al. Live/real time three-dimensional echocardiographic demonstration of left ventricular noncompaction and thrombi. Echocardiography 2006; 23(8): 704-6.
14. Cevik C, Stainback RF. Isolated left ventricular noncompaction in a 90-year-old man. Tex Heart Inst J 2012; 39(2): 255-7.
15. Stöllberger C, Wegner C, Finsterer J. CHADS2and CHA2DS2VASc scores and embolic risk in left ventricular hypertrabeculation/noncompaction. J Stroke and Cerebrovascular Diseases 2013; 22(6): 709-12.
16. Fazio G, Corrado G, Zachara E, et al. Anticoagulant drugs in noncompaction: a mandatory therapy? J Cardiovasc Med (Hagerstown) 2008; 9(11): 1095-7.
17. Myasnikov RP, Blagova OV, Kulikova OV, et al. The specifics of noncompacted cardiomyopathy manifestation. Cardiovascular Therapy and Prevention. 2015; 14(5): 78-82. Russian (Мясников Р. П., Благова О. В., Куликова О. В. др. Особенности манифестации некомпактной кардиомиопатии. Кардиоваскулярная терапия и профилактика 2015; 14(5): 78-82).
Review
For citations:
Myasnikov R.P., Kulikova О.V., Kharlap М.S., Koretsky S.N., Andreenko Е.Yu., Mershina E.A., Sinitsin V.Е., Boytsov S.А. NON-COMPACTION MYOCARDIUM OF THE LEFT VENTRICLE: SECONDARY PREVENTION OF THROMBOEMBOLISM. Cardiovascular Therapy and Prevention. 2017;16(1):100-104. (In Russ.) https://doi.org/10.15829/1728-8800-2017-1-100-104